Drug candidates and potential targets ofCurculigospp. compounds for treating diabetes mellitus based on network pharmacology, molecular docking and molecular dynamics simulation
- 27 October 2022
- journal article
- research article
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 41 (17) , 8544-8560
Abstract
Curculigo spp. is a herb that is commonly used in Indonesia to treat diabetes mellitus (DM) . The main active components of Curculigo spp. were identified through our previous metabolomic study and online database platform. However, the biological mechanisms underlying Curculigo spp. activity in treating DM remain unclear. Therefore, in this study, a network pharmacology was used to explore the active compounds of Curculigo spp. and their potential molecular mechanisms for treating DM. Oral bioavailability and drug-likeness from the compounds of Curculigo spp. were screened using Lipinski’s rule of five, BBB, HIA + and Caco-2 permeability criteria. A network of compound–target–disease–pathway was then constructed using Cytoscape. The highest degree compounds and targets were then confirmed by molecular docking and molecular dynamics (MD) simulations. The human body can absorb 33 compounds derived from Curculigo spp. In addition, 58 nodes and 62 edges generated a network analysis with the DM target. The highest degree of the compound–target–disease pathway was for orcinol glucoside, AKR1B1, autoimmune diabetes, bile acid and bile salt metabolism. Furthermore, the computational docking method on Curculigo spp. compounds with the highest degree revealed that orcinol glucoside interacted with PTPN1 through a hydrogen bond and resulted in a binding energy of −7.2 kcal mol−1. Through hydrogen bonds, orcinol glucoside in PTPN1 regulates multiple signaling pathways via the adherens junction pathway, which may play a therapeutic role in DM (type 2 diabetes: obesity). In addition, MD simulation confirmed that orcinol glucoside, is suitable for DM treatment by interacting with PTPN1. Communicated by Ramaswamy H. SarmaKeywords
This publication has 66 references indexed in Scilit:
- Insulin Receptor Signaling in Normal and Insulin-Resistant StatesCold Spring Harbor Perspectives in Biology, 2014
- A Drug-Target Network-Based Approach to Evaluate the Efficacy of Medicinal Plants for Type II Diabetes MellitusEvidence-Based Complementary and Alternative Medicine, 2013
- Use of Natural Products as Chemical Library for Drug Discovery and Network PharmacologyPLOS ONE, 2013
- A travel guide to Cytoscape pluginsNature Methods, 2012
- Networking for new drugsNature Medicine, 2011
- Comparison of Computational Methods to Model DNA Minor Groove BindersJournal of Chemical Information and Modeling, 2011
- Natural products in drug discoveryDrug Discovery Today, 2008
- CHARMM‐GUI: A web‐based graphical user interface for CHARMMJournal of Computational Chemistry, 2008
- Lead- and drug-like compounds: the rule-of-five revolutionDrug Discovery Today: Technologies, 2004
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Advanced Drug Delivery Reviews, 2001